Signature Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 6.48 M
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -9.45%
- Profit Growth -179.37%
- Ebitda -81.95%
- Net Worth -2.05%
- Total Assets -2.09%
About Signature Pharmaceuticals
Signature Pharmaceuticals Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 03 February 1995 and has a history of 29 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.48 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Agarwal, Sanjiv Garg, and Vinita Agarwal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1995PLC085225
-
Company No.
085225
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
03 Feb 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Signature Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinita Agarwal
|
Director | 03-Feb-1995 | Current |
|
Sanjiv Garg
|
Director | 03-Feb-1995 | Current |
|
Krishnakumar Agarwal
|
Director | 03-Feb-1995 | Current |
Financial Performance of Signature Pharmaceuticals.
Signature Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.45% decrease. The company also saw a substantial fall in profitability, with a 179.37% decrease in profit. The company's net worth dipped by a decrease of 2.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Signature Pharmaceuticals?
In 2022, Signature Pharmaceuticals had a promoter holding of 58.36% and a public holding of 41.64%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hab Pharmaceuticals And Research LimitedKrishnakumar Agarwal, Sanjiv Garg and 1 more are mutual person
-
Asim Software Solutions Private LimitedKrishnakumar Agarwal, Sanjiv Garg and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Signature Pharmaceuticals?
Unlock and access historical data on people associated with Signature Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Signature Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Signature Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.